➡️ The U.S. Food and Drug Administration plans to extend eligibility for boosters of the Pfizer/BioNTech vaccine to to 12- to 15-year-olds.
➡️ They also plan to reduce the minimum wait time for 3rd doses from 6 months to 5 months after the 2nd dose.
➡️ A booster shot is also expected to be authorized for children aged 5 to 11 with immune deficiencies.
Rough timeline:
FDA approvals expected Monday, with Centers for Disease Control and Prevention’s vaccine advisory committee meeting in the “middle of the week” to vote on changes, followed by final endorsement by CDC Director Dr. Rochelle P. Walensky.
That’s all the detail we have for now but many have been asking questions about this so we wanted to share!
Link:
